Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,336 | 817 | 99.5% |
| Education | $80.86 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,930 | 151 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,457 | 79 | $0 (2024) |
| Grifols USA, LLC | $1,374 | 72 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,323 | 63 | $0 (2024) |
| ABBVIE INC. | $901.64 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $765.82 | 31 | $0 (2024) |
| Amgen Inc. | $681.07 | 34 | $0 (2024) |
| GENZYME CORPORATION | $622.49 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $592.25 | 21 | $0 (2024) |
| PFIZER INC. | $571.33 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,071 | 99 | GlaxoSmithKline, LLC. ($277.88) |
| 2023 | $2,672 | 118 | Regeneron Healthcare Solutions, Inc. ($346.57) |
| 2022 | $1,950 | 101 | Grifols USA, LLC ($203.69) |
| 2021 | $2,168 | 119 | AbbVie Inc. ($262.16) |
| 2020 | $1,470 | 89 | Grifols USA, LLC ($268.39) |
| 2019 | $1,962 | 110 | GlaxoSmithKline, LLC. ($318.96) |
| 2018 | $1,622 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($320.04) |
| 2017 | $1,501 | 83 | GlaxoSmithKline, LLC. ($239.74) |
All Payment Transactions
818 individual payment records from CMS Open Payments — Page 3 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Bone Health | ||||||
| 05/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Bone Health | ||||||
| 05/20/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: VTE | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Biological | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Immunology | ||||||
| 03/25/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,133 | 1,726 | $243,577 | $167,594 |
| 2022 | 9 | 1,128 | 1,642 | $246,397 | $162,137 |
| 2021 | 8 | 1,054 | 1,423 | $261,896 | $137,938 |
| 2020 | 11 | 1,302 | 1,789 | $270,475 | $141,277 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 777 | $122,155 | $81,739 | 66.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 227 | 227 | $36,660 | $32,284 | 88.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 216 | 222 | $48,840 | $30,991 | 63.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $14,027 | $9,276 | 66.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 25 | $8,550 | $6,045 | 70.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 131 | 180 | $6,163 | $4,220 | 68.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 160 | 174 | $3,132 | $2,084 | 66.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 54 | 54 | $4,050 | $955.26 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 702 | $117,796 | $76,551 | 65.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $37,302 | $31,958 | 85.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 215 | 218 | $50,444 | $29,858 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $15,443 | $9,465 | 61.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 20 | $6,778 | $4,983 | 73.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 113 | 158 | $5,949 | $3,684 | 61.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $2,911 | $2,415 | 83.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 167 | 182 | $4,917 | $2,098 | 42.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 63 | 63 | $4,858 | $1,126 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 226 | 559 | $118,647 | $60,766 | 51.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 212 | 214 | $62,975 | $29,655 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 178 | 178 | $38,864 | $26,315 | 67.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $16,318 | $8,162 | 50.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 32 | 32 | $8,945 | $6,007 | 67.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 96 | 121 | $6,359 | $3,306 | 52.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 171 | 180 | $4,624 | $2,284 | 49.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 80 | 80 | $5,164 | $1,444 | 28.0% |
About Dr. William Klein, MD
Dr. William Klein, MD is a Internal Medicine healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205834819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Klein, MD has received a total of $15,417 in payments from pharmaceutical and medical device companies, with $2,071 received in 2024. These payments were reported across 818 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($15,336).
As a Medicare-enrolled provider, Klein has provided services to 4,617 Medicare beneficiaries, totaling 6,580 services with total Medicare billing of $608,946. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newport Beach, CA
- Active Since 07/08/2005
- Last Updated 01/17/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205834819
Products in Payments
- DUPIXENT (Biological) $1,164
- TRELEGY ELLIPTA (Drug) $1,147
- Prolastin-C Liquid (Biological) $1,106
- XOLAIR (Biological) $930.69
- OFEV (Drug) $676.08
- NUCALA (Biological) $612.67
- UBRELVY (Drug) $409.64
- XARELTO (Drug) $395.07
- STIOLTO RESPIMAT (Drug) $359.12
- AVYCAZ (Drug) $342.81
- EVENITY (Biological) $330.50
- SAMSCA (Drug) $308.85
- Prolastin-C (Biological) $247.23
- FLOWTRIEVER CATHETER, S (Device) $244.41
- Xolair (Biological) $230.83
- ELIQUIS (Drug) $222.09
- PANZYGA (Biological) $192.38
- JANUVIA (Drug) $182.59
- SPIRIVA RESPIMAT (Drug) $182.20
- TRULICITY (Drug) $180.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport Beach
Daniel Nadeau, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ehab Mady, D.o, D.O
Internal Medicine — Payments: $256,298
Ryan Klein, Md, MD
Internal Medicine — Payments: $159,192
Wael Harb, Md, MD
Internal Medicine — Payments: $130,572
Laura Salazar, Md, MD
Internal Medicine — Payments: $129,472
David Brouwer, Md, MD
Internal Medicine — Payments: $71,027